US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 5.350
  • -0.380-6.63%
Close May 6 16:00 ET
  • 5.350
  • 0.0000.00%
Post 19:52 ET
288.79MMarket Cap-535.00P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
Net income from continuing operations
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
Depreciation and amortization
-26.30%353K
-26.66%1.59M
-27.36%369K
-30.51%369K
-33.69%376K
-15.37%479K
-10.02%2.17M
-14.04%508K
-13.09%531K
-16.12%567K
Change In working capital
86.47%-223K
7.91%-4.25M
-103.10%-2.09M
73.92%-410K
-112.31%-96K
40.93%-1.65M
-49.10%-4.61M
-132.43%-1.03M
80.88%-1.57M
-72.74%780K
-Change in receivables
108.01%1.12M
-406.17%-1.56M
3,527.91%1.56M
-1,840.79%-1.32M
-318.85%-2.33M
313.08%537K
-109.04%-308K
-92.51%43K
-74.41%76K
-86.91%-557K
-Change in prepaid assets
128.14%1.83M
-27.33%-1.37M
66.72%-207K
-250.29%-2.42M
-39.40%463K
253.83%803K
-530.59%-1.07M
-181.20%-622K
27.99%-692K
1,176.06%764K
-Change in payables and accrued expense
-6.24%-3M
-56.44%-2.63M
-3,727.17%-3.34M
369.48%1.6M
107.17%1.94M
-33.63%-2.82M
-170.21%-1.68M
-96.27%92K
91.53%-593K
-83.92%934K
-Change in other current assets
--0
2,028.72%2M
414.29%66K
38,160.00%1.91M
-102.78%-1K
-68.92%23K
106.02%94K
-250.00%-21K
-28.57%5K
102.79%36K
-Change in other working capital
7.89%-175K
57.55%-700K
66.35%-176K
52.72%-174K
59.70%-160K
47.37%-190K
60.26%-1.65M
15.65%-523K
34.05%-368K
69.18%-397K
Cash from discontinued investing activities
Operating cash flow
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
Investing cash flow
Cash flow from continuing investing activities
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
Net PPE purchase and sale
--0
45.28%-278K
-200.00%-231K
70.77%-19K
--0
83.63%-28K
74.12%-508K
33.62%-77K
77.03%-65K
85.20%-195K
Net investment purchase and sale
-102.04%-777K
189.84%32.51M
-86.48%2.49M
-77.11%4.37M
-162.32%-12.51M
140.69%38.16M
-351.70%-36.18M
150.85%18.43M
1,056.16%19.09M
-38.65%20.07M
Cash from discontinued investing activities
Investing cash flow
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
Financing cash flow
Cash flow from continuing financing activities
0
-97.68%2.75M
-71.08%83K
635K
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
0
-94.95%142K
Net common stock issuance
----
--0
--0
--0
--0
--0
45.22%117.35M
--0
--0
--0
Proceeds from stock option exercised by employees
--0
253.41%2.75M
-71.08%83K
--635K
165.49%377K
374.43%1.65M
-77.92%777K
7.49%287K
--0
-94.95%142K
Cash from discontinued financing activities
Financing cash flow
--0
-97.68%2.75M
-71.08%83K
--635K
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
--0
-94.95%142K
Net cash flow
Beginning cash position
122.90%59.41M
-26.35%26.66M
136.85%73.83M
150.78%87.92M
14.86%41.15M
-26.35%26.66M
-0.86%36.19M
-66.13%31.17M
-15.00%35.06M
4.13%35.83M
Current changes in cash
-210.62%-16.03M
443.56%32.76M
-219.19%-14.42M
-262.51%-14.09M
6,189.58%46.77M
4,082.14%14.5M
-2,936.62%-9.54M
91.91%-4.52M
-107.65%-3.89M
-111.23%-768K
End cash Position
5.42%43.38M
122.90%59.41M
122.90%59.41M
136.85%73.83M
150.78%87.92M
14.86%41.15M
-26.35%26.66M
-26.35%26.66M
-66.13%31.17M
-15.00%35.06M
Free cash flow
39.72%-15.26M
97.27%-2.5M
26.87%-16.99M
16.89%-19.09M
380.74%58.9M
-4.22%-25.31M
7.62%-91.47M
-17.28%-23.24M
18.44%-22.97M
26.86%-20.98M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M
Net income from continuing operations 34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M
Depreciation and amortization -26.30%353K-26.66%1.59M-27.36%369K-30.51%369K-33.69%376K-15.37%479K-10.02%2.17M-14.04%508K-13.09%531K-16.12%567K
Change In working capital 86.47%-223K7.91%-4.25M-103.10%-2.09M73.92%-410K-112.31%-96K40.93%-1.65M-49.10%-4.61M-132.43%-1.03M80.88%-1.57M-72.74%780K
-Change in receivables 108.01%1.12M-406.17%-1.56M3,527.91%1.56M-1,840.79%-1.32M-318.85%-2.33M313.08%537K-109.04%-308K-92.51%43K-74.41%76K-86.91%-557K
-Change in prepaid assets 128.14%1.83M-27.33%-1.37M66.72%-207K-250.29%-2.42M-39.40%463K253.83%803K-530.59%-1.07M-181.20%-622K27.99%-692K1,176.06%764K
-Change in payables and accrued expense -6.24%-3M-56.44%-2.63M-3,727.17%-3.34M369.48%1.6M107.17%1.94M-33.63%-2.82M-170.21%-1.68M-96.27%92K91.53%-593K-83.92%934K
-Change in other current assets --02,028.72%2M414.29%66K38,160.00%1.91M-102.78%-1K-68.92%23K106.02%94K-250.00%-21K-28.57%5K102.79%36K
-Change in other working capital 7.89%-175K57.55%-700K66.35%-176K52.72%-174K59.70%-160K47.37%-190K60.26%-1.65M15.65%-523K34.05%-368K69.18%-397K
Cash from discontinued investing activities
Operating cash flow 39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M
Investing cash flow
Cash flow from continuing investing activities -102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M
Net PPE purchase and sale --045.28%-278K-200.00%-231K70.77%-19K--083.63%-28K74.12%-508K33.62%-77K77.03%-65K85.20%-195K
Net investment purchase and sale -102.04%-777K189.84%32.51M-86.48%2.49M-77.11%4.37M-162.32%-12.51M140.69%38.16M-351.70%-36.18M150.85%18.43M1,056.16%19.09M-38.65%20.07M
Cash from discontinued investing activities
Investing cash flow -102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M
Financing cash flow
Cash flow from continuing financing activities 0-97.68%2.75M-71.08%83K635K165.49%377K-98.60%1.65M40.08%118.12M31.65%287K0-94.95%142K
Net common stock issuance ------0--0--0--0--045.22%117.35M--0--0--0
Proceeds from stock option exercised by employees --0253.41%2.75M-71.08%83K--635K165.49%377K374.43%1.65M-77.92%777K7.49%287K--0-94.95%142K
Cash from discontinued financing activities
Financing cash flow --0-97.68%2.75M-71.08%83K--635K165.49%377K-98.60%1.65M40.08%118.12M31.65%287K--0-94.95%142K
Net cash flow
Beginning cash position 122.90%59.41M-26.35%26.66M136.85%73.83M150.78%87.92M14.86%41.15M-26.35%26.66M-0.86%36.19M-66.13%31.17M-15.00%35.06M4.13%35.83M
Current changes in cash -210.62%-16.03M443.56%32.76M-219.19%-14.42M-262.51%-14.09M6,189.58%46.77M4,082.14%14.5M-2,936.62%-9.54M91.91%-4.52M-107.65%-3.89M-111.23%-768K
End cash Position 5.42%43.38M122.90%59.41M122.90%59.41M136.85%73.83M150.78%87.92M14.86%41.15M-26.35%26.66M-26.35%26.66M-66.13%31.17M-15.00%35.06M
Free cash flow 39.72%-15.26M97.27%-2.5M26.87%-16.99M16.89%-19.09M380.74%58.9M-4.22%-25.31M7.62%-91.47M-17.28%-23.24M18.44%-22.97M26.86%-20.98M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Inverse ETF Inverse ETF
No. Symbol Turnover
Sample Name
Sample Code
 1.27B
Sample Name
Sample Code
 506.96M
Sample Name
Sample Code
 349.37M
4
ProShares UltraPro Short S&P500 ETF
SPXU
274.07M
5
Short S&P 500 Proshares
SH
252.14M
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 11.300
Sample Name
Sample Code
 382.980
Sample Name
Sample Code
 13.150
4
Salesforce
CRM
273.360
5
Vale SA
VALE
9.310
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 127.660
Sample Name
Sample Code
 382.980
Sample Name
Sample Code
 139.900
4
Netflix
NFLX
1137.690
5
Salesforce
CRM
273.360
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 10.920
Sample Name
Sample Code
 6.500
Sample Name
Sample Code
 3.120
4
Mawson Infrastructure
MIGI
0.5980
5
Cipher Mining
CIFR
3.040
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -